Bayer AG (XTER:BAYN) Selling and Marketing Expense : €12,482 Mil (TTM As of Dec. 2023)

View and export this data going back to 1953. Start your Free Trial

What is Bayer AG Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Bayer AG's Selling and Marketing Expense for the three months ended in Dec. 2023 was €2,839 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €12,482 Mil.

Bayer AG Selling and Marketing Expense Historical Data

The historical data trend for Bayer AG's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Selling and Marketing Expense Chart

Bayer AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Selling and Marketing Expense

Get a 7-Day Free Trial

12,489.00

13,053.00

12,363.00

14,084.00

12,482.00

Bayer AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Selling and Marketing Expense	Get a 7-Day Free Trial															3,706.00	3,394.00	3,196.00	3,053.00	2,839.00

Bayer AG Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €12,482 Mil.

Bayer AG Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Bayer AG's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bayer AG (XTER:BAYN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

BAYZF:USA BAYRY:USA BAYN:Romania BAY:Poland BAYN:Mexico BAY:Italy BAYER:Hungary 0P6S:UK BAYNd:UK BAYN:Austria

Address

Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368

Website

https://www.bayer.com

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (XTER:BAYN) Headlines

From GuruFocus

Oakmark International Fund Buys Fresenius Medical Care AG. KGaA, Anheuser-Busch InBev SA/NV, Bayer AG, Sells NAVER Corp, Daimler AG, Valeo SA

By GuruFocus Research GuruFocus Editor • 11-30-2020

Market Indexes Lower as Market Considers Outlook

By Julie Young Julie Young • 05-23-2016

Analysts Think Bayer Shares Have Huge Upside

By Barry Cohen Barry Cohen • 03-04-2019

Oakmark International Fund Buys Bayer AG, Roche Holding AG, Fresenius Medical Care AG. KGaA, Sells BNP Paribas, Baidu Inc, CNH Industrial NV

By GuruFocus Research GuruFocus Editor • 03-01-2021

Bayer AG Expects Currency to Ding Earnings by $191.5 Million

By Jacob Maslow Jacob Maslow • 05-21-2018

David Herro Comments on Bayer

By Holly LaFon Holly LaFon • 04-06-2018